Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets. (11th May 2017)

• Record Type: Journal Article
• Authors: Guven, Ayla; Al‐Rijjal, Roua A.; BinEssa, Huda A.; Dogan, Durmuş; Kor, Yılmaz; Zou, Minjing; Kaya, Namik; Alenezi, Anwar F.; Hancili, Suna; Tarım, Ömer; Baitei, Essa Y.; Kattan, Walaa E; Meyer, Brian F.; Shi, Yufei
• Is Part Of: Clinical endocrinology. Volume 87:Number 1(2017)
• Page Start: 103
• Page End: 112
• Publication Date: 2017-05-11
• Subjects: CLCN5 -- FGF23 -- hypophosphataemia -- PHEX -- rickets; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.13347
• Languages: English
• ISSNs: 0300-0664

Abstract

Summary: Context: Hypophosphataemic rickets (HR) is a group of rare hereditary renal phosphate wasting disorders caused by mutations in PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3 . Objective: To investigate underlying genetic defects in patients with hypophosphataemic rickets. Methods: We analysed genomic DNA from nine unrelated families for mutations in the entire coding region of PHEX, FGF23, DMP1, ENPP1, CLCN5 or SLC34A3 by PCR sequencing and copy number analysis. Results: A total of 14 patients were studied. PHEX mutations were identified in 12 patients from seven families. Five of them were novel mutations present in eight patients: c.154G>T (p.E52*), c.401_402insGCCAAA (p.Q134_K135insPK), c.1600C>T (p.P534S), g.22016715_22056805del (40‐kb deletion including promoter and exons 1‐3) and c.2242_2243delCT (p.L748 fs*48). Four patients had previously reported mutations: c.1768+1G>A and c.1807G>A (p.W602*). Novel CLCN5 (c.1205G>A, p.W402*) and FGF23 (c.526C>G, p.R176G) mutations were found in two patients from the remaining two families. Many of the mutations were de novo: c.154G>T and c.2242_2243delCT in PHEX and c.526C>G in FGF23 . Furthermore, we characterized the breakpoint of the novel PHEX g.22016715_22056805del and the c.2242_2243delCT, which is 6 bp from the stop codon, resulting in a frameshift and extension of the reading frame by 42 amino acids. Conclusions: Novel and de novo mutations are frequent and PHEX mutations are still the most common genetic defects in the Turkish population. Gene copy number analysis should be considered in patients with negative results by conventional PCR‐based sequencing analysis. The current study further expands the mutation spectrum underlying HR.